Organon Reports Results for the First Quarter Ended March 31, 2022
Go back to Organon Reports Results for the First Quarter Ended March 31, 2022| Merck & Co. (NYSE: MRK) | Delayed: 147.15 +2.24 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.91 | 52 Week High | $65.46 | |||
| Open | $145.74 | 52 Week Low | $47.97 | |||
| Day High | $147.65 | P/E | 100.10 | |||
| Day Low | $145.32 | EPS | $1.47 | |||
| Volume | 11,063,719 | |||||
| (NYSE: OGN) | Delayed: 13.69 +0.02 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.67 | 52 Week High | $8.00 | |||
| Open | $13.67 | 52 Week Low | $8.00 | |||
| Day High | $13.69 | P/E | N/A | |||
| Day Low | $13.66 | EPS | $0.00 | |||
| Volume | 1,263,364 | |||||
